Christina Shay
2PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Oct 21, 2024
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study.Gisle Langslet, Thomas Nyström, Dorte Vistisen
|Sep 14, 2020
Muscle insulin resistance in type 1 diabetes with coronary artery disease.Katherine V Williams, Christina M Shay, Julie C Price
Pageof 1
